B cell development is regulated by stromal cells (SCs) that form a supportive microenvironment.
INTRODUCTION
About 80% of the antibody produced in mammals is IgA. The main function of IgA antibodies is to maintain homeostasis. In response to the colonization of commensal microbes, B cells in the gut-associated lymphoid tissue (GALT) produce large amounts of IgA, a dimeric secretory antibody responsible for the blockade of bacterial penetration.
IgA class switch recombination (CSR) and plasma cell differentiation in GALT is influenced by metabolic products and cytokines produced by activated epithelial cells, stromal cells (SCs), dendritic cells, B cells, and T cells within the microenvironment. [1] [2] [3] [4] [5] Among all these cell types, the contribution of SCs has until recently been largely neglected. SCs are nonhematopoietic cells that form a supportive matrix, which can also influence the immune response. 6 Therefore, understanding the interaction between SCs and lymphocytes becomes important. In this study, we focused on SCs derived from gut lamina propria (LP), BM, and spleen (Sp).
Abbreviations: APRIL, a proliferation-inducing ligand; BAFF, B-cell activating factor; CM, conditioned medium; CSR, class switch recombination; FM, fecal matter; GALT, gut-associated lymphoid tissue; IFN R, interferon receptor; LC-MS/MS, liquid chromatography-tandem mass spectrometry; LP, lamina propria; MCP-1, monocyte chemotactic protein-1; MSC, mesenchymal stromal cells; SC, stromal cell; Sp, spleen/splenic; VEGF, vascular endothelial growth factor germinal centers. However, several studies have found that BM is a site for B cell maturation and T-independent IgM plasma cell differentiation in response to blood-borne microbes. 18, 19 On the other hand, the Sp is a secondary lymphoid organ responsible for the maturation, activation, and differentiation of B cells. 20 Within the white pulp, follicular dendritic cells, fibroblastic reticular cells, and marginal reticular cells are the most studied SC types. 20 After infection or immunization, Sp follicular B cells preferentially switch to IgG, and IgG + plasma cells are found in the red pulp. 21, 22 However, to add to the complexity, in mice, both B1 cells and marginal zone B cells in the Sp contribute to IgA production in vitro. 23 The reason why IgA CSR does not predominantly take place within the BM and Sp is largely unknown. It could be possible that BM and Sp microenvironments actively inhibit IgA + plasma cell generation. 
MATERIALS AND METHODS

Stromal cell preparation
Female C57BL/6 mice were sacrificed and small intestines were harvested. Detailed protocols for intestine digestion have been described in our previous published article. 24 Cells from the small intestine were To prepare the SCs for staining, SCs were treated with PBS with 1 mM EDTA for 5-10 min at room temperature (25 • C) on a shaking platform. Remaining adherent SCs were lifted by cell scrapers. SCs were stained following manufacturer's instructions.
B cell-SC co-culture
B lineage cells were harvested from the femurs and tibias of C56BL/6 mice and were isolated using a CD19 positive selection kit (Mojosort Jose, California, United States) was added at 5 g/mL.
Cell lines
NS451 is a gut LP SC line isolated from the gut LP primary stroma of a B6 CD45.1 mouse. It was established through repeated passaging. Additional gut LP SC lines, LPSC1, LPSC2, LPSC3, LPSC4, LPSC5, LPSC6, and LPSC7, were established by limiting dilution of the adherent cells derived from the gut LP primary stroma from B6 mice. 
Flow cytometry
Enzyme-linked immunospot
Preparation of conditioned medium
SCs were irradiated at 2000 cGy, and different cell numbers were plated. SCs were plated on day 0 in 500 L complete medium supplemented with the cocktail of factors mentioned above. A control well was set up to contain 500 L of complete medium supplemented with the factors. On day 4, 500 L complete medium was added to cultures to achieve 1 mL total conditioned medium (CM). On day 6, 
Liquid chromatography-tandem mass spectrometry
Conditioned medium for mass spectrometry analysis was prepared by plating 500,000 stromal cells from gut LP, BM, and Sp in 10 mL complete medium supplemented with the factors in T75 flasks. SCs were irradiated at 2000 cGy on day 0 and cultured for 5 days. On day 5, SCs were washed 3 times using PBS and re-suspended using serum free IMDM medium. On day 6, supernatant was collected. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was performed by SPARC BioCentre (Toronto, Canada). ThermoFisher LTQ Ion
Trap Mass Spectrometer was used to collect data. LC-MS/MS data was analyzed by Scaffold 4, Maxquant, and Perseus Software. Z-score with P ≤ 0.05 was plotted on an expression heatmap. Viability of IgA + B cells was assessed on days 0, 2, 4 using the Zombie UV viability dye and cell counting.
Dual chamber assays
B cell assays
In vitro generated IgA + B cell survival was assessed on selected IgA + B cell proliferation assay was performed using a CFSE cell proliferation kit (ThermoFisher, Waltham, Massachusetts, United States).
A total of 100,000 PE-selected IgA + B cells were stained with CFSE following manufacturer's protocol. CFSE-stained IgA + B cell were cocultured with 20,000 SCs. Proliferation of IgA + B cells was assessed on hours 0, 18, 48, and 72 after CFSE staining using FACS. 
Differentiation of IgA + B cells is optimized in the presence of gut LP-derived SCs
To test whether SCs from distinctive anatomical compartments exert different effects on IgA + B cell generation, we followed our published protocol that promotes the differentiation of IgA + B cells in an in vitro culture system. 24 This entailed seeding BM-derived CD19-selected B lineage cells into cultures containing IL-7, anti-CD40, TGF , IL-21, fecal matter, and either gut LP (from small intestines), BM-or Sp-derived SCs for 6 days. Gut LP SCs strongly enhanced the accumulation of IgA + B cells (Fig. 1A) . However, SCs established from the BM or Sp failed to provide similar support (Figs. 1A) . This finding was based both on total IgA + B cells detected on day 6 of cultures using flow cytometry (Fig. 1A) as well as in an ELISPOT assay measuring IgA secreting cells (Fig. 1B) . were co-cultured with LP stroma, whereas they were almost absent when BM stroma or Sp stroma was present (Fig. 1C) . A part of the in vitro generated IgA + B cells underwent terminal differentiation as evidenced by Blimp-1 expression, while others underwent proliferation. In the presence of gut LP SCs but not with BM or Sp SCs, a large number of IgA + B cells was proliferating (Fig. 1D ).
To accurately establish the basis of the stimulatory effect on IgA + B cells, we selected IgA + B cells derived from a 6-day gut LP-CD19 + B cell co-culture and plated them with different stromal conditions ( Fig. 1E-H) . We evaluated the stimulatory activity of gut SCs on IgA + B cells in CFSE-based proliferation assays. Proliferation of living IgA + B cells showed no significant difference when IgA + B cells were plated with different SCs (Fig. 1E and F BM stroma was present, whereas IgA + B cells survived better when gut LP stroma was present after 72 h (Fig. 1G) . The amount of IgA antibodies secreted into culture was also different when IgA + B cells were co-cultured with different SCs (Fig. 1H) . IgA + B cells arose from gut LP co-cultures produced IgA; however, the level of IgA secretion was not affected by the presence of SCs (statistically significant difference was found between gut LP and BM stroma; however, no statistical significance was detected when it was compared to no stroma control) (Fig. 1H) . In other words, once B cells differentiated into IgA + B cells, they are programed to secrete IgA antibodies regardless of the microenvironment, with occasionally enhancement from gut LP stroma (Fig. 1H) .
To further explore our culture conditions, we titrated each of the added factors and monitored the production of IgA + B cells ( Fig. 2A) . IL-7 was added to promote pro-B and pre-B cell survival and proliferation. 24 IL-21 was added to promote B cell maturation and terminal differentiation. 24 TGF was added to enhance IgA CSR, while anti-CD40 was added to induce B cell activation. 24 Fecal matter (FM) was essential in priming gut LP SCs in promoting IgA + iNOS + cell development according to our previous published work, and this work also confirmed its role in priming gut LP SCs in promoting IgA + B cell accumulation. 24 We found that each of these factors enhanced the production of IgA + B cells but only in the presence of gut LP-derived SCs and other factors (Fig. 2A) . Again, BM-and Sp-derived SCs failed to induce a large accumulation of IgA + B cells, implying gut LP SCs secreted additional stimulatory factors (Fig. 2A) . To study the development and accumulation of IgA + B cells in vitro over time, we set up time-course experiments and analyzed the composition of the cocultures on a daily basis (Fig. 2B ). This experiment demonstrated that IgA + B cells typically started to accumulate on day 5, and underwent an expansion during the subsequent days when co-cultured with gut LP stroma (Fig. 2B) . However, an expansion of IgA + B cells was not detected when B cells were plated with BM or Sp stroma (Fig. 2B) . (Fig. 2D), indicating that the proliferation of pre-existing IgA + B cells was not responsible for the accumulation of IgA + B cells on day 6. As a result, using a heterogeneous CD19-selected population from the BM was a reasonable approach for future experiments.
Primary stroma contains a heterogeneous population of cells, which includes cell types such as endothelial cells and fibroblasts. To identify the different cell types of the primary stroma, we stained the adherent layers derived from gut LP, BM, and Sp using the common stromal cell marker GP38 and CD31 with lymphatic endothelial cells being CD45 − GP38 + CD31 + , fibroblastic reticular cells being CD45 − GP38 + CD31 − , blood endothelial cells being CD45 − GP38 − CD31 + , and double negative cells being CD45 − GP38 − CD31 − . 6 Gut SCs had a relatively homogenous fibroblastic reticular cell phenotype, while BM SCs and splenic stromal cells contained a heterogeneous population (Fig. 2E) . To reduce the level of complexity, we established and tested cell lines to determine if they could recapitulate the effect of primary stroma. We cloned multiple F I G U R E 2 Development of the in vitro system measuring stromal effects on IgA + B cells. (A) Factors were titrated. Unless being titrated, factors were provided at the following concentrations: IL-7 at 0.5 ng/mL, CD40 at 2 g/mL, TGF at 2.5 ng/mL, IL-21 at 30 ng/mL, and FM at 1EU/mL. Statistical significance was based on two-way ANOVA on 3 independent experiments. Error bar was shown in SD. (B) Time course analysis was performed on the accumulation of IgA + B cells in culture with 200,000 CD19 + BM cells as starting population. Statistical significance was based on two-way ANOVA on 3 independent experiments. (C) B lineage cells gave rise to IgA + B cells in culture. Different B cell subsets were sorted based on CD19, CD2, IgM, IgD, and BP.1 expression (Material and Methods). Sorted B cell subsets were co-cultured with SCs following our usual protocol. IgA + B cell number was assessed on day 6. (D) Survival of IgA + B cells was assessed. IgA+ B cells sorted from the BM stained with CyToxiLux R cell tracker dye were co-cultured with 190,000 CD19 + B cells and 20,000 SCs. Viability of IgA + B cells was assayed on day 0, 2, 4, and 6 by tracing the number of cell-tracker-dye + IgA + B cells in vitro. (E) SCs from gut LP, BM, and Sp were stained using CD45, GP38, and CD31. CD45 + population in gut LP SCs is <1%, BM 4%, and Sp 5%. (F) Capacity of different gut LP SC lines to induce IgA + B cell accumulation was measured in vitro. NS451, LPSC1-7 lines were gut LP cell lines while PA6 was a BM cell line. Statistical significance was based on one-way ANOVA on 3 independent experiments cell lines from the gut LP stroma by limiting dilution. Characterizing cell lines using CD45, GP38, and CD31 markers indicated that NS451, PA6, LPSC1, LPSC4, LPSC5, and LPSC6 were CD45 − GP38 + CD31 − , while LPSC2 and LPSC3 were CD45 − GP38 + CD31 + . LPSC7 contained both CD45 − GP38 + CD31 − and CD45 − GP38 + CD31 + subsets (data not shown). Regarding IgA-promoting effects, there was considerable heterogeneity with some gut LP lines having a positive effect while others did not (Fig 2F) . This finding indicated that the gut LP stroma indeed contained a heterogeneous population of cells with different IgA-promoting capacities, and some of which were similar to primary LP stroma.
Stromal-derived soluble factors play a role in the regulation of IgA + B cells in vitro
We next wanted to determine whether soluble factors secreted by SCs or contact-dependent mechanisms were responsible for the accumulation of IgA + B cells in vitro. We determined the number of gut LP SCs needed to elicit IgA-promoting effects by titrating the gut LP SCs. Conditioned medium (CM) from the same number of SCs was provided to the starting B cell population and we found similar levels of IgA + B cell production, indicating soluble factors played a major role in the regulation of IgA + B cells (Fig. 3A) . CM from 10,000 gut LP SCs was enough to induce a large number of IgA + B cells accumulated in vitro with no significant difference detected with higher number of SCs plated (Fig. 3A) . A total of 20,000 SCs were plated for all co-culture experiments to achieve a 1:10 ratio of 1 stromal cell to 10 input B cells.
To examine the roles of soluble factors from different stromal environment, we utilized a dual chamber culture system. While optimizing the dual chamber experiment, we found that the addition of Cytodex I microcarriers to the upper chambers was necessary as SCs could not effectively adhere to the membranes of the upper wells, and Scs required attachment to surfaces to survive and secrete factors (data not shown). The addition of gut LP stroma in the top chamber had equal IgA-promoting effects as when gut LP stroma was in the bottom chamber with B cells (Fig. 3B) , indicating again that soluble factors played a major role in the induction of IgA + B cells in vitro. In contrast, both BM stroma and Sp stroma exhibited inhibitory effects on IgA + B cell accumulation in a dual chamber system with gut LP stroma (Fig. 3B) . When the BM or Sp SCs were in the top chamber and gut LP stroma with B cells were placed in the bottom chamber, the number of IgA + B cells recovered from a 6-day co-culture was significantly lower than when B cells were with gut LP SCs in the bottom but without BM or Sp SCs in the top chamber (Fig. 3B) . When gut LP stroma was in the top chamber and BM or Sp stroma with B cells in the bottom chamber, there was a trend, albeit not significant, toward a reduction on IgA + B cell numbers (Fig. 3B ). This suggests that B cells in contact with gut LP stroma might have an additional influence on the IgA-promoting capacities of gut LP stroma. (Fig. 3C) . This indicates that the inhibitory effect of BM stroma or Sp stroma in Fig. 3B was due to the soluble factors secreted by BM stroma or Sp stroma that might inhibit the secretion of pro-IgA factors from gut LP. Consistent with this, the positive effect from the addition of gut LP CM to B cell-BM SC or B cell-Sp SC co-cultures was not diminished (Fig. 3C) , further 
BAFF stimulates the accumulation of IgA + B cells in vitro
We were interested in elucidating the role of BAFF in the co-culture system, as it is an essential positive regulator of IgA + B cell development. To examine the effect of BAFF in culture, we performed a BAFF neutralization assay (Fig. 4A) . The addition of anti-BAFF blocking antibodies decreased the number of IgA + B cells recovered from B cellgut LP stroma co-cultures, indicating that BAFF was one of the major contributors of IgA + B cell development (Fig. 4A) .
Since BAFF played a role in the accumulation of IgA + B cells in vitro, we wondered if the addition of BAFF to cultures with BM or Sp stroma increased the number of IgA + B cells. Interestingly, the addition of BAFF resulted in an increase in IgA + B cells in cultures without stroma but not in cultures containing either BM or Sp stroma (Fig. 4B) . To elucidate the mechanism behind this antagonistic effect, we examined B cell proliferation. We found that the cocktail of factors (containing IL-7, IL-21, TGF , CD40, and FM) with BAFF alone (and no stroma) was sufficient to induce proliferating IgA + B cells, but in the presence of BM or splenic stroma, proliferating IgA + B cells were not increased (Fig. 4C) . Flow plots of Fig. 4C demonstrated that the addition of BAFF increased the percentage of both total proliferating cells and proliferating IgA + B cells in control wells without SCs (Fig. 4D) . However, in the presence of BM or Sp SCs, such increase was not observed, suggesting that BM and Sp stroma exerted a negative influence on the proliferation of BAFF-treated IgA + B cells (Fig. 4D) . Such inhibitory effect could be either directly impacting on IgA + B cells responding to BAFF, or indirectly via BAFF neutralization. It led us to investigate the presence of inhibitory factors using mass spectrometry.
Mass spectrometric analysis of stromal cell secreted factors
We demonstrated that soluble factors play a role both in the stimulation and inhibition of IgA + B cell accumulation in vitro. Specifically, BAFF is a major contributor to the stimulatory effect. However, the addition of anti-BAFF antibodies even at high concentrations could not fully ablate the induction of IgA + B cells, suggesting that other factors besides BAFF might play a role (Fig. 4A) . We also determined that BM and Sp stroma secreted soluble inhibitory factors. As a result, a proteomic analysis to identify these factors is necessary.
In order to screen for other possible soluble factors, we performed a LC-MS/MS analysis on the supernatant of SCs (Figs. 5A and B) .
Approximately 1593 proteins were quantified using the LC-MS/MS method, and a large proportion (420/1593) of the detected proteins was found across all the 3 SC subsets (Fig. 5A ). BM and Sp stroma shared a more similar secretion pattern than gut LP stroma (Fig. 5B) .
Among all the differentially secreted proteins, a group of proteins from the complement system (C1s, C1ra, C4b) was highly expressed by gut (Fig. 5C ). MCP-1 itself was not sufficient to induce IgA + B cell accumulation since the addition of recombinant MCP-1 protein to B cell cultures showed no significant inductive effect (Fig. 5C ).
DISCUSSION
Our previous published work has detailed an important role for gut LP SCs in the generation of IgA + iNOS + plasma cells. 24 secreted by macrophages, dendritic cells, and mesenchymal SCs. 30, 31 In this study, we have found that MCP-1 is necessary but not sufficient such as sBCMA or sTACI as they were found in physiological conditions to neutralize BAFF and APRIL. [27] [28] [29] It has been shown in both in vitro and in vivo studies that both BM and Sp sites promote plasma cell survival and differentiation. 21, 34 In particular, BM niche promotes long-term survival of IgA + plasma cells. 34, 35 As a result, there are positive regulators in both BM and Sp microenvironments. However, in this in vitro setting, we propose that the inhibitory effect by BM or Sp stroma on IgA + B cell generation dominates.
Inevitably, this in vitro system has some caveats. First, gut LP, BM, and splenic primary stroma contains a heterogeneous population of SCs, and our in vitro system might not fully recapitulate the contribution and interaction of all SCs in vivo. Our data confirmed previous publications that freshly isolated gut stroma contain four populations: CD45 − GP38 + CD31 + lymphatic endothelial cells, CD45 − GP38 + CD31 − fibroblastic reticular cells, CD45 − GP38 − CD31 + blood endothelial cells, and CD45 − GP38 − CD31 − double negative cells. 36 
